A Study of QLS31905 in Patients With Advanced Solid Tumors
Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
This is a multi-center, open-label design to evaluate the safety and tolerance of QLS31905 in
patients with advanced solid tumors, together with an assessment of pharmacokinetic
characteristics and efficacy.